Labetuzumab

Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. It selectively binds to carcinoembryonic cell adhesion molecule 5.

This drug was developed by Immunomedics, Inc.

单词	Labetuzumab
释义	Labetuzumab 英语百科 Labetuzumab Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. It selectively binds to carcinoembryonic cell adhesion molecule 5. This drug was developed by Immunomedics, Inc.
随便看	option bill option blank option board option bond option book option box option button option buttons option buyer option card Option Chain option character option charge option circuit option class option clause option code option command option component record option consumption Option contract option date option day option dealer option dealing